Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
21201
21202
21203
21204
21205
21206
21207
21208
21209
21210
21211
21212
21213
21214
21215
21216
21217
21218
21219
21220
21221
21222
21223
21224
21225
21226
21227
21228
21229
21230
21231
21232
21233
21234
21235
21236
21237
21238
21239
21240
21241
21242
21243
21244
21245
21246
21247
21248
21249
21250
21251
21252
21253
21254
21255
21256
21257
21258
21259
21260
21261
21262
21263
21264
21265
21266
21267
21268
21269
21270
21271
21272
21273
21274
21275
21276
21277
21278
21279
21280
21281
21282
21283
21284
21285
21286
21287
21288
21289
21290
21291
21292
21293
21294
21295
21296
21297
21298
21299
21300
21301
21302
21303
21304
21305
21306
21307
21308
21309
21310
21311
21312
21313
21314
21315
21316
21317
21318
21319
21320
21321
21322
21323
21324
21325
21326
21327
21328
21329
21330
21331
21332
21333
21334
21335
21336
21337
21338
21339
21340
21341
21342
21343
21344
21345
21346
21347
21348
21349
21350
21351
21352
21353
21354
21355
21356
21357
21358
21359
21360
21361
21362
21363
21364
21365
21366
21367
21368
21369
21370
21371
21372
21373
21374
21375
21376
21377
21378
21379
21380
21381
21382
21383
21384
21385
21386
21387
21388
21389
21390
21391
21392
21393
21394
21395
21396
21397
21398
21399
21400
| UnnamedSample_HQ_transcript/9805|m.3766 | UnnamedSample_HQ_transcript/9805 | Coverage 0.884 too low. | 06d21b9917fa9b847067ae46beef46b4 | 1014 | Pfam | PF12661 | Human growth factor-like EGF | 504 | 523 | 0.021 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/9805|m.3766 | UnnamedSample_HQ_transcript/9805 | Coverage 0.884 too low. | 06d21b9917fa9b847067ae46beef46b4 | 1014 | Pfam | PF07974 | EGF-like domain | 591 | 616 | 8.8E-5 | T | 22-09-2020 | IPR013111 | EGF-like domain, extracellular |
| UnnamedSample_HQ_transcript/12873|m.4778 | UnnamedSample_HQ_transcript/12873 | Coverage 0.874 too low. | 06d21b9917fa9b847067ae46beef46b4 | 1014 | Pfam | PF00053 | Laminin EGF domain | 545 | 584 | 0.0016 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/12873|m.4778 | UnnamedSample_HQ_transcript/12873 | Coverage 0.874 too low. | 06d21b9917fa9b847067ae46beef46b4 | 1014 | Pfam | PF00053 | Laminin EGF domain | 415 | 459 | 2.8E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/12873|m.4778 | UnnamedSample_HQ_transcript/12873 | Coverage 0.874 too low. | 06d21b9917fa9b847067ae46beef46b4 | 1014 | Pfam | PF00053 | Laminin EGF domain | 282 | 327 | 0.014 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/12873|m.4778 | UnnamedSample_HQ_transcript/12873 | Coverage 0.874 too low. | 06d21b9917fa9b847067ae46beef46b4 | 1014 | Pfam | PF12661 | Human growth factor-like EGF | 242 | 260 | 0.071 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/12873|m.4778 | UnnamedSample_HQ_transcript/12873 | Coverage 0.874 too low. | 06d21b9917fa9b847067ae46beef46b4 | 1014 | Pfam | PF12661 | Human growth factor-like EGF | 723 | 742 | 0.0052 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/12873|m.4778 | UnnamedSample_HQ_transcript/12873 | Coverage 0.874 too low. | 06d21b9917fa9b847067ae46beef46b4 | 1014 | Pfam | PF12661 | Human growth factor-like EGF | 504 | 523 | 0.021 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/12873|m.4778 | UnnamedSample_HQ_transcript/12873 | Coverage 0.874 too low. | 06d21b9917fa9b847067ae46beef46b4 | 1014 | Pfam | PF07974 | EGF-like domain | 591 | 616 | 8.8E-5 | T | 22-09-2020 | IPR013111 | EGF-like domain, extracellular |
| UnnamedSample_HQ_transcript/3990|m.1804 | UnnamedSample_HQ_transcript/3990 | Coverage 0.903 too low. | 06d21b9917fa9b847067ae46beef46b4 | 1014 | Pfam | PF00053 | Laminin EGF domain | 545 | 584 | 0.0016 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3990|m.1804 | UnnamedSample_HQ_transcript/3990 | Coverage 0.903 too low. | 06d21b9917fa9b847067ae46beef46b4 | 1014 | Pfam | PF00053 | Laminin EGF domain | 415 | 459 | 2.8E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3990|m.1804 | UnnamedSample_HQ_transcript/3990 | Coverage 0.903 too low. | 06d21b9917fa9b847067ae46beef46b4 | 1014 | Pfam | PF00053 | Laminin EGF domain | 282 | 327 | 0.014 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3990|m.1804 | UnnamedSample_HQ_transcript/3990 | Coverage 0.903 too low. | 06d21b9917fa9b847067ae46beef46b4 | 1014 | Pfam | PF12661 | Human growth factor-like EGF | 242 | 260 | 0.071 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/3990|m.1804 | UnnamedSample_HQ_transcript/3990 | Coverage 0.903 too low. | 06d21b9917fa9b847067ae46beef46b4 | 1014 | Pfam | PF12661 | Human growth factor-like EGF | 723 | 742 | 0.0052 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/3990|m.1804 | UnnamedSample_HQ_transcript/3990 | Coverage 0.903 too low. | 06d21b9917fa9b847067ae46beef46b4 | 1014 | Pfam | PF12661 | Human growth factor-like EGF | 504 | 523 | 0.021 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/3990|m.1804 | UnnamedSample_HQ_transcript/3990 | Coverage 0.903 too low. | 06d21b9917fa9b847067ae46beef46b4 | 1014 | Pfam | PF07974 | EGF-like domain | 591 | 616 | 8.8E-5 | T | 22-09-2020 | IPR013111 | EGF-like domain, extracellular |
| UnnamedSample_HQ_transcript/93628|m.21754 | UnnamedSample_HQ_transcript/93628 | Coverage 0.590 too low. | af656e65fc1a530eef1f2da313b665e8 | 360 | Pfam | PF01130 | CD36 family | 2 | 330 | 7.7E-92 | T | 22-09-2020 | IPR002159 | CD36 family |
| UnnamedSample_HQ_transcript/74044|m.18652 | UnnamedSample_HQ_transcript/74044 | Coverage 0.745 too low. | 9b0c3712f9940e1bf9c24d3a6bd64443 | 380 | Pfam | PF00096 | Zinc finger, C2H2 type | 246 | 266 | 0.0038 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/74044|m.18652 | UnnamedSample_HQ_transcript/74044 | Coverage 0.745 too low. | 9b0c3712f9940e1bf9c24d3a6bd64443 | 380 | Pfam | PF00651 | BTB/POZ domain | 27 | 119 | 9.6E-23 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/74044|m.18652 | UnnamedSample_HQ_transcript/74044 | Coverage 0.745 too low. | 9b0c3712f9940e1bf9c24d3a6bd64443 | 380 | Pfam | PF13894 | C2H2-type zinc finger | 300 | 323 | 1.4E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/62832|m.16600 | UnnamedSample_HQ_transcript/62832 | Coverage 0.656 too low. | 9b0c3712f9940e1bf9c24d3a6bd64443 | 380 | Pfam | PF00096 | Zinc finger, C2H2 type | 246 | 266 | 0.0038 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/62832|m.16600 | UnnamedSample_HQ_transcript/62832 | Coverage 0.656 too low. | 9b0c3712f9940e1bf9c24d3a6bd64443 | 380 | Pfam | PF00651 | BTB/POZ domain | 27 | 119 | 9.6E-23 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/62832|m.16600 | UnnamedSample_HQ_transcript/62832 | Coverage 0.656 too low. | 9b0c3712f9940e1bf9c24d3a6bd64443 | 380 | Pfam | PF13894 | C2H2-type zinc finger | 300 | 323 | 1.4E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/58446|m.15736 | UnnamedSample_HQ_transcript/58446 | Coverage 0.638 too low. | 9b0c3712f9940e1bf9c24d3a6bd64443 | 380 | Pfam | PF00096 | Zinc finger, C2H2 type | 246 | 266 | 0.0038 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/58446|m.15736 | UnnamedSample_HQ_transcript/58446 | Coverage 0.638 too low. | 9b0c3712f9940e1bf9c24d3a6bd64443 | 380 | Pfam | PF00651 | BTB/POZ domain | 27 | 119 | 9.6E-23 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/58446|m.15736 | UnnamedSample_HQ_transcript/58446 | Coverage 0.638 too low. | 9b0c3712f9940e1bf9c24d3a6bd64443 | 380 | Pfam | PF13894 | C2H2-type zinc finger | 300 | 323 | 1.4E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/100759|m.22730 | UnnamedSample_HQ_transcript/100759 | Identity 0.781 too low. | af4a4e4fa0960f3c601a58192050ea78 | 309 | Pfam | PF07993 | Male sterility protein | 32 | 302 | 1.0E-65 | T | 22-09-2020 | IPR013120 | Male sterility, NAD-binding |
| UnnamedSample_HQ_transcript/47116|m.13396 | UnnamedSample_HQ_transcript/47116 | Coverage 0.796 too low. | a14dd4af6003afcc01f946fb81c683f2 | 619 | Pfam | PF00732 | GMC oxidoreductase | 55 | 354 | 8.7E-75 | T | 22-09-2020 | IPR000172 | Glucose-methanol-choline oxidoreductase, N-terminal |
| UnnamedSample_HQ_transcript/47116|m.13396 | UnnamedSample_HQ_transcript/47116 | Coverage 0.796 too low. | a14dd4af6003afcc01f946fb81c683f2 | 619 | Pfam | PF05199 | GMC oxidoreductase | 461 | 605 | 1.9E-38 | T | 22-09-2020 | IPR007867 | Glucose-methanol-choline oxidoreductase, C-terminal |
| UnnamedSample_HQ_transcript/13229|m.4876 | UnnamedSample_HQ_transcript/13229 | Coverage 0.932 too low. | d43c7d77d71431134d04b7f3f5fa0c8f | 662 | Pfam | PF04910 | Transcriptional repressor TCF25 | 218 | 546 | 4.0E-97 | T | 22-09-2020 | IPR006994 | TCF25/Rqc1 |
| UnnamedSample_HQ_transcript/115868|m.24478 | UnnamedSample_HQ_transcript/115868 | Coverage 0.359 too low. | 9c9fa3374f56bfa634ec97ff36468c13 | 133 | Pfam | PF05653 | Magnesium transporter NIPA | 2 | 90 | 5.1E-34 | T | 22-09-2020 | IPR008521 | Magnesium transporter NIPA |
| UnnamedSample_HQ_transcript/36838|m.11125 | UnnamedSample_HQ_transcript/36838 | Coverage 0.493 too low. | 822e3bf7a2018d2c17d4a18e2fa2bbf2 | 423 | Pfam | PF00045 | Hemopexin | 317 | 363 | 3.0E-10 | T | 22-09-2020 | IPR018487 | Hemopexin-like repeats |
| UnnamedSample_HQ_transcript/36838|m.11125 | UnnamedSample_HQ_transcript/36838 | Coverage 0.493 too low. | 822e3bf7a2018d2c17d4a18e2fa2bbf2 | 423 | Pfam | PF00045 | Hemopexin | 175 | 218 | 7.0E-8 | T | 22-09-2020 | IPR018487 | Hemopexin-like repeats |
| UnnamedSample_HQ_transcript/36838|m.11125 | UnnamedSample_HQ_transcript/36838 | Coverage 0.493 too low. | 822e3bf7a2018d2c17d4a18e2fa2bbf2 | 423 | Pfam | PF00045 | Hemopexin | 272 | 313 | 1.1E-11 | T | 22-09-2020 | IPR018487 | Hemopexin-like repeats |
| UnnamedSample_HQ_transcript/36838|m.11125 | UnnamedSample_HQ_transcript/36838 | Coverage 0.493 too low. | 822e3bf7a2018d2c17d4a18e2fa2bbf2 | 423 | Pfam | PF00045 | Hemopexin | 221 | 264 | 2.4E-16 | T | 22-09-2020 | IPR018487 | Hemopexin-like repeats |
| UnnamedSample_HQ_transcript/36838|m.11125 | UnnamedSample_HQ_transcript/36838 | Coverage 0.493 too low. | 822e3bf7a2018d2c17d4a18e2fa2bbf2 | 423 | Pfam | PF00413 | Matrixin | 1 | 122 | 7.4E-47 | T | 22-09-2020 | IPR001818 | Peptidase M10, metallopeptidase |
| UnnamedSample_HQ_transcript/105212|m.23254 | UnnamedSample_HQ_transcript/105212 | Coverage 0.670 too low. | f4580a69b36b77b66038647f8422d75a | 174 | Pfam | PF16363 | GDP-mannose 4,6 dehydratase | 1 | 160 | 6.2E-65 | T | 22-09-2020 | IPR016040 | NAD(P)-binding domain |
| UnnamedSample_HQ_transcript/12894|m.4787 | UnnamedSample_HQ_transcript/12894 | Coverage 0.170 too low. | fbfe0d13acf40c51bbfda87103235abb | 928 | Pfam | PF07686 | Immunoglobulin V-set domain | 27 | 111 | 1.5E-7 | T | 22-09-2020 | IPR013106 | Immunoglobulin V-set domain |
| UnnamedSample_HQ_transcript/12894|m.4787 | UnnamedSample_HQ_transcript/12894 | Coverage 0.170 too low. | fbfe0d13acf40c51bbfda87103235abb | 928 | Pfam | PF13895 | Immunoglobulin domain | 554 | 628 | 2.5E-7 | T | 22-09-2020 | IPR007110 | Immunoglobulin-like domain |
| UnnamedSample_HQ_transcript/12894|m.4787 | UnnamedSample_HQ_transcript/12894 | Coverage 0.170 too low. | fbfe0d13acf40c51bbfda87103235abb | 928 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 253 | 332 | 2.4E-7 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/12894|m.4787 | UnnamedSample_HQ_transcript/12894 | Coverage 0.170 too low. | fbfe0d13acf40c51bbfda87103235abb | 928 | Pfam | PF13927 | Immunoglobulin domain | 839 | 908 | 4.2E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/12894|m.4787 | UnnamedSample_HQ_transcript/12894 | Coverage 0.170 too low. | fbfe0d13acf40c51bbfda87103235abb | 928 | Pfam | PF13927 | Immunoglobulin domain | 352 | 428 | 2.8E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/12894|m.4787 | UnnamedSample_HQ_transcript/12894 | Coverage 0.170 too low. | fbfe0d13acf40c51bbfda87103235abb | 928 | Pfam | PF00047 | Immunoglobulin domain | 156 | 233 | 2.8E-8 | T | 22-09-2020 | IPR013151 | Immunoglobulin |
| UnnamedSample_HQ_transcript/87206|m.20823 | UnnamedSample_HQ_transcript/87206 | Identity 0.405 too low. | a1576559045ef3db7ad2a4dd3fc98ca9 | 156 | Pfam | PF00462 | Glutaredoxin | 51 | 115 | 3.6E-21 | T | 22-09-2020 | IPR002109 | Glutaredoxin |
| UnnamedSample_HQ_transcript/43954|m.12708 | UnnamedSample_HQ_transcript/43954 | Coverage 0.749 too low. | 877e7ed43e5a945235ceeb9ac738131d | 535 | Pfam | PF16134 | THO complex subunit 2 N-terminus | 53 | 410 | 1.5E-49 | T | 22-09-2020 | IPR032302 | THO complex subunit 2, N-terminal domain |
| UnnamedSample_HQ_transcript/43954|m.12708 | UnnamedSample_HQ_transcript/43954 | Coverage 0.749 too low. | 877e7ed43e5a945235ceeb9ac738131d | 535 | Pfam | PF16134 | THO complex subunit 2 N-terminus | 437 | 534 | 1.1E-13 | T | 22-09-2020 | IPR032302 | THO complex subunit 2, N-terminal domain |
| UnnamedSample_HQ_transcript/80363|m.19774 | UnnamedSample_HQ_transcript/80363 | Unmapped. | 4ca29ae4147a6305ea33a9023a9b998c | 436 | Pfam | PF00910 | RNA helicase | 55 | 163 | 8.6E-19 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/86913|m.20788 | UnnamedSample_HQ_transcript/86913 | Coverage 0.984 too low. | 76973f2cf8ae2f747dffa1010ca8ba51 | 268 | Pfam | PF00704 | Glycosyl hydrolases family 18 | 2 | 240 | 4.3E-59 | T | 22-09-2020 | IPR001223 | Glycoside hydrolase family 18, catalytic domain |
| UnnamedSample_HQ_transcript/73375|m.18538 | UnnamedSample_HQ_transcript/73375 | Coverage 0.227 too low. | 660fbe4f1107e5cf7086e771d71529a6 | 448 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.5E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/77916|m.19360 | UnnamedSample_HQ_transcript/77916 | Coverage 0.059 too low. | 14ddcf81944088adfe05eae9ca501665 | 249 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 67 | 103 | 2.7E-7 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/32460|m.10068 | UnnamedSample_HQ_transcript/32460 | Coverage 0.270 too low. | e051eb4b75a15a6162eecd68f94bdbb6 | 509 | Pfam | PF00069 | Protein kinase domain | 204 | 459 | 1.5E-71 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/32460|m.10068 | UnnamedSample_HQ_transcript/32460 | Coverage 0.270 too low. | e051eb4b75a15a6162eecd68f94bdbb6 | 509 | Pfam | PF07679 | Immunoglobulin I-set domain | 4 | 81 | 4.1E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/32460|m.10068 | UnnamedSample_HQ_transcript/32460 | Coverage 0.270 too low. | e051eb4b75a15a6162eecd68f94bdbb6 | 509 | Pfam | PF00041 | Fibronectin type III domain | 97 | 170 | 1.5E-11 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/106322|m.23375 | UnnamedSample_HQ_transcript/106322 | Coverage 0.986 too low. | 02c5d75c5201f992e05e0802add3faa5 | 321 | Pfam | PF00043 | Glutathione S-transferase, C-terminal domain | 86 | 151 | 1.0E-7 | T | 22-09-2020 | IPR004046 | Glutathione S-transferase, C-terminal |
| UnnamedSample_HQ_transcript/106322|m.23375 | UnnamedSample_HQ_transcript/106322 | Coverage 0.986 too low. | 02c5d75c5201f992e05e0802add3faa5 | 321 | Pfam | PF00749 | tRNA synthetases class I (E and Q), catalytic domain | 201 | 320 | 6.6E-45 | T | 22-09-2020 | IPR020058 | Glutamyl/glutaminyl-tRNA synthetase, class Ib, catalytic domain |
| UnnamedSample_HQ_transcript/5440|m.2346 | UnnamedSample_HQ_transcript/5440 | Coverage 0.568 too low. | 5eab11620cc6810e06c9a99ad6509bb5 | 398 | Pfam | PF07525 | SOCS box | 355 | 394 | 1.3E-9 | T | 22-09-2020 | IPR001496 | SOCS box domain |
| UnnamedSample_HQ_transcript/5440|m.2346 | UnnamedSample_HQ_transcript/5440 | Coverage 0.568 too low. | 5eab11620cc6810e06c9a99ad6509bb5 | 398 | Pfam | PF00622 | SPRY domain | 219 | 342 | 7.5E-19 | T | 22-09-2020 | IPR003877 | SPRY domain |
| UnnamedSample_HQ_transcript/84815|m.20462 | UnnamedSample_HQ_transcript/84815 | Unmapped. | db02fbc394dd9505b2fce4b6e26290c3 | 445 | Pfam | PF00772 | DnaB-like helicase N terminal domain | 24 | 125 | 9.2E-35 | T | 22-09-2020 | IPR007693 | DNA helicase, DnaB-like, N-terminal |
| UnnamedSample_HQ_transcript/84815|m.20462 | UnnamedSample_HQ_transcript/84815 | Unmapped. | db02fbc394dd9505b2fce4b6e26290c3 | 445 | Pfam | PF03796 | DnaB-like helicase C terminal domain | 203 | 445 | 6.1E-105 | T | 22-09-2020 | IPR007694 | DNA helicase, DnaB-like, C-terminal |
| UnnamedSample_HQ_transcript/7937|m.3161 | UnnamedSample_HQ_transcript/7937 | Identity 0.859 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 1120 | 1160 | 2.2E-7 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/7937|m.3161 | UnnamedSample_HQ_transcript/7937 | Identity 0.859 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 1206 | 1249 | 1.3E-8 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/7937|m.3161 | UnnamedSample_HQ_transcript/7937 | Identity 0.859 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 1164 | 1203 | 1.9E-13 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/7937|m.3161 | UnnamedSample_HQ_transcript/7937 | Identity 0.859 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF07474 | G2F domain | 318 | 499 | 8.1E-52 | T | 22-09-2020 | IPR006605 | G2 nidogen/fibulin G2F |
| UnnamedSample_HQ_transcript/7937|m.3161 | UnnamedSample_HQ_transcript/7937 | Identity 0.859 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF07645 | Calcium-binding EGF domain | 601 | 636 | 5.2E-11 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/7937|m.3161 | UnnamedSample_HQ_transcript/7937 | Identity 0.859 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF07645 | Calcium-binding EGF domain | 694 | 735 | 1.3E-6 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/7937|m.3161 | UnnamedSample_HQ_transcript/7937 | Identity 0.859 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF12947 | EGF domain | 1031 | 1067 | 7.1E-7 | T | 22-09-2020 | IPR024731 | EGF domain |
| UnnamedSample_HQ_transcript/7937|m.3161 | UnnamedSample_HQ_transcript/7937 | Identity 0.859 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF12947 | EGF domain | 824 | 861 | 8.8E-7 | T | 22-09-2020 | IPR024731 | EGF domain |
| UnnamedSample_HQ_transcript/7937|m.3161 | UnnamedSample_HQ_transcript/7937 | Identity 0.859 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF06119 | Nidogen-like | 165 | 249 | 3.3E-19 | T | 22-09-2020 | IPR003886 | NIDO domain |
| UnnamedSample_HQ_transcript/7937|m.3161 | UnnamedSample_HQ_transcript/7937 | Identity 0.859 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF12661 | Human growth factor-like EGF | 660 | 678 | 0.041 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/8723|m.3424 | UnnamedSample_HQ_transcript/8723 | Identity 0.875 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 1120 | 1160 | 2.2E-7 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/8723|m.3424 | UnnamedSample_HQ_transcript/8723 | Identity 0.875 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 1206 | 1249 | 1.3E-8 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/8723|m.3424 | UnnamedSample_HQ_transcript/8723 | Identity 0.875 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 1164 | 1203 | 1.9E-13 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/8723|m.3424 | UnnamedSample_HQ_transcript/8723 | Identity 0.875 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF07474 | G2F domain | 318 | 499 | 8.1E-52 | T | 22-09-2020 | IPR006605 | G2 nidogen/fibulin G2F |
| UnnamedSample_HQ_transcript/8723|m.3424 | UnnamedSample_HQ_transcript/8723 | Identity 0.875 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF07645 | Calcium-binding EGF domain | 601 | 636 | 5.2E-11 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/8723|m.3424 | UnnamedSample_HQ_transcript/8723 | Identity 0.875 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF07645 | Calcium-binding EGF domain | 694 | 735 | 1.3E-6 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/8723|m.3424 | UnnamedSample_HQ_transcript/8723 | Identity 0.875 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF12947 | EGF domain | 1031 | 1067 | 7.1E-7 | T | 22-09-2020 | IPR024731 | EGF domain |
| UnnamedSample_HQ_transcript/8723|m.3424 | UnnamedSample_HQ_transcript/8723 | Identity 0.875 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF12947 | EGF domain | 824 | 861 | 8.8E-7 | T | 22-09-2020 | IPR024731 | EGF domain |
| UnnamedSample_HQ_transcript/8723|m.3424 | UnnamedSample_HQ_transcript/8723 | Identity 0.875 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF06119 | Nidogen-like | 165 | 249 | 3.3E-19 | T | 22-09-2020 | IPR003886 | NIDO domain |
| UnnamedSample_HQ_transcript/8723|m.3424 | UnnamedSample_HQ_transcript/8723 | Identity 0.875 too low. | 1eb5cd468d3b2921e3300bd97a2e131c | 1337 | Pfam | PF12661 | Human growth factor-like EGF | 660 | 678 | 0.041 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/82279|m.20075 | UnnamedSample_HQ_transcript/82279 | Identity 0.916 too low. | 3a6c9eaee767b3a6581c1fdf02436933 | 202 | Pfam | PF01557 | Fumarylacetoacetate (FAA) hydrolase family | 4 | 194 | 4.2E-34 | T | 22-09-2020 | IPR011234 | Fumarylacetoacetase-like, C-terminal |
| UnnamedSample_HQ_transcript/104407|m.23155 | UnnamedSample_HQ_transcript/104407 | Coverage 0.840 too low. | a0459e996a3a6e77255e65264a044c1c | 195 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 2 | 58 | 8.5E-16 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/104407|m.23155 | UnnamedSample_HQ_transcript/104407 | Coverage 0.840 too low. | a0459e996a3a6e77255e65264a044c1c | 195 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 63 | 172 | 2.7E-43 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/61616|m.16374 | UnnamedSample_HQ_transcript/61616 | Coverage 0.164 too low. | 52b81440ae9fedec2217a01102332d9c | 400 | Pfam | PF00400 | WD domain, G-beta repeat | 252 | 279 | 0.17 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/61616|m.16374 | UnnamedSample_HQ_transcript/61616 | Coverage 0.164 too low. | 52b81440ae9fedec2217a01102332d9c | 400 | Pfam | PF00400 | WD domain, G-beta repeat | 94 | 139 | 8.7E-6 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/61616|m.16374 | UnnamedSample_HQ_transcript/61616 | Coverage 0.164 too low. | 52b81440ae9fedec2217a01102332d9c | 400 | Pfam | PF03451 | HELP motif | 18 | 90 | 4.0E-32 | T | 22-09-2020 | IPR005108 | HELP |
| UnnamedSample_HQ_transcript/34001|m.10464 | UnnamedSample_HQ_transcript/34001 | Coverage 0.307 too low. | 8644bda40ca126f073615c454f7ed517 | 775 | Pfam | PF13646 | HEAT repeats | 474 | 564 | 6.2E-13 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/34001|m.10464 | UnnamedSample_HQ_transcript/34001 | Coverage 0.307 too low. | 8644bda40ca126f073615c454f7ed517 | 775 | Pfam | PF18004 | 26S proteasome regulatory subunit RPN2 C-terminal domain | 660 | 773 | 7.0E-23 | T | 22-09-2020 | IPR040623 | 26S proteasome regulatory subunit RPN2, C-terminal |
| UnnamedSample_HQ_transcript/78102|m.19388 | UnnamedSample_HQ_transcript/78102 | Coverage 0.975 too low. | f401a47b594087051a374fe6ad4b135a | 396 | Pfam | PF00135 | Carboxylesterase family | 1 | 378 | 3.8E-64 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/24715|m.8137 | UnnamedSample_HQ_transcript/24715 | Identity 0.646 too low. | 051fadff1e1b2c51ba91b2f085ed4477 | 265 | Pfam | PF01553 | Acyltransferase | 57 | 189 | 1.1E-28 | T | 22-09-2020 | IPR002123 | Phospholipid/glycerol acyltransferase |
| UnnamedSample_HQ_transcript/30718|m.9644 | UnnamedSample_HQ_transcript/30718 | Identity 0.628 too low. | 051fadff1e1b2c51ba91b2f085ed4477 | 265 | Pfam | PF01553 | Acyltransferase | 57 | 189 | 1.1E-28 | T | 22-09-2020 | IPR002123 | Phospholipid/glycerol acyltransferase |
| UnnamedSample_HQ_transcript/36610|m.11073 | UnnamedSample_HQ_transcript/36610 | Coverage 0.939 too low. | 7a453ccb3afcda75898882b71c9cc310 | 288 | Pfam | PF02793 | Hormone receptor domain | 42 | 106 | 4.7E-13 | T | 22-09-2020 | IPR001879 | GPCR, family 2, extracellular hormone receptor domain |
| UnnamedSample_HQ_transcript/36610|m.11073 | UnnamedSample_HQ_transcript/36610 | Coverage 0.939 too low. | 7a453ccb3afcda75898882b71c9cc310 | 288 | Pfam | PF00002 | 7 transmembrane receptor (Secretin family) | 117 | 266 | 2.4E-36 | T | 22-09-2020 | IPR000832 | GPCR, family 2, secretin-like |
| UnnamedSample_HQ_transcript/87867|m.20915 | UnnamedSample_HQ_transcript/87867 | Coverage 0.896 too low. | 11a369548ca2286ce42219856760f1dd | 302 | Pfam | PF00385 | Chromo (CHRromatin Organisation MOdifier) domain | 14 | 62 | 1.3E-12 | T | 22-09-2020 | IPR023780 | Chromo domain |
| UnnamedSample_HQ_transcript/93371|m.21719 | UnnamedSample_HQ_transcript/93371 | Coverage 0.958 too low. | 11a369548ca2286ce42219856760f1dd | 302 | Pfam | PF00385 | Chromo (CHRromatin Organisation MOdifier) domain | 14 | 62 | 1.3E-12 | T | 22-09-2020 | IPR023780 | Chromo domain |
| UnnamedSample_HQ_transcript/82730|m.20152 | UnnamedSample_HQ_transcript/82730 | Coverage 0.818 too low. | 11a369548ca2286ce42219856760f1dd | 302 | Pfam | PF00385 | Chromo (CHRromatin Organisation MOdifier) domain | 14 | 62 | 1.3E-12 | T | 22-09-2020 | IPR023780 | Chromo domain |
| UnnamedSample_HQ_transcript/83032|m.20202 | UnnamedSample_HQ_transcript/83032 | Coverage 0.707 too low. | f5619335f59036ada74c39ee68c65137 | 302 | Pfam | PF00168 | C2 domain | 144 | 262 | 1.4E-7 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/68629|m.17695 | UnnamedSample_HQ_transcript/68629 | Coverage 0.849 too low. | d4691e2276eabea19262c6ee4bb2986b | 285 | Pfam | PF13639 | Ring finger domain | 240 | 279 | 1.1E-6 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/36953|m.11154 | UnnamedSample_HQ_transcript/36953 | Identity 0.649 too low. | def3ab1fb88b8ed4dfc4665eb1f5c64a | 225 | Pfam | PF00642 | Zinc finger C-x8-C-x5-C-x3-H type (and similar) | 15 | 38 | 2.4E-7 | T | 22-09-2020 | IPR000571 | Zinc finger, CCCH-type |
| UnnamedSample_HQ_transcript/36953|m.11154 | UnnamedSample_HQ_transcript/36953 | Identity 0.649 too low. | def3ab1fb88b8ed4dfc4665eb1f5c64a | 225 | Pfam | PF00642 | Zinc finger C-x8-C-x5-C-x3-H type (and similar) | 152 | 176 | 1.7E-5 | T | 22-09-2020 | IPR000571 | Zinc finger, CCCH-type |
| UnnamedSample_HQ_transcript/36953|m.11154 | UnnamedSample_HQ_transcript/36953 | Identity 0.649 too low. | def3ab1fb88b8ed4dfc4665eb1f5c64a | 225 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 94 | 142 | 5.5E-6 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/94658|m.21898 | UnnamedSample_HQ_transcript/94658 | Coverage 0.119 too low. | def3ab1fb88b8ed4dfc4665eb1f5c64a | 225 | Pfam | PF00642 | Zinc finger C-x8-C-x5-C-x3-H type (and similar) | 15 | 38 | 2.4E-7 | T | 22-09-2020 | IPR000571 | Zinc finger, CCCH-type |
| UnnamedSample_HQ_transcript/94658|m.21898 | UnnamedSample_HQ_transcript/94658 | Coverage 0.119 too low. | def3ab1fb88b8ed4dfc4665eb1f5c64a | 225 | Pfam | PF00642 | Zinc finger C-x8-C-x5-C-x3-H type (and similar) | 152 | 176 | 1.7E-5 | T | 22-09-2020 | IPR000571 | Zinc finger, CCCH-type |
| UnnamedSample_HQ_transcript/94658|m.21898 | UnnamedSample_HQ_transcript/94658 | Coverage 0.119 too low. | def3ab1fb88b8ed4dfc4665eb1f5c64a | 225 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 94 | 142 | 5.5E-6 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/96352|m.22146 | UnnamedSample_HQ_transcript/96352 | Coverage 0.124 too low. | def3ab1fb88b8ed4dfc4665eb1f5c64a | 225 | Pfam | PF00642 | Zinc finger C-x8-C-x5-C-x3-H type (and similar) | 15 | 38 | 2.4E-7 | T | 22-09-2020 | IPR000571 | Zinc finger, CCCH-type |
| UnnamedSample_HQ_transcript/96352|m.22146 | UnnamedSample_HQ_transcript/96352 | Coverage 0.124 too low. | def3ab1fb88b8ed4dfc4665eb1f5c64a | 225 | Pfam | PF00642 | Zinc finger C-x8-C-x5-C-x3-H type (and similar) | 152 | 176 | 1.7E-5 | T | 22-09-2020 | IPR000571 | Zinc finger, CCCH-type |
| UnnamedSample_HQ_transcript/96352|m.22146 | UnnamedSample_HQ_transcript/96352 | Coverage 0.124 too low. | def3ab1fb88b8ed4dfc4665eb1f5c64a | 225 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 94 | 142 | 5.5E-6 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/102886|m.22977 | UnnamedSample_HQ_transcript/102886 | Coverage 0.604 too low. | def3ab1fb88b8ed4dfc4665eb1f5c64a | 225 | Pfam | PF00642 | Zinc finger C-x8-C-x5-C-x3-H type (and similar) | 15 | 38 | 2.4E-7 | T | 22-09-2020 | IPR000571 | Zinc finger, CCCH-type |
| UnnamedSample_HQ_transcript/102886|m.22977 | UnnamedSample_HQ_transcript/102886 | Coverage 0.604 too low. | def3ab1fb88b8ed4dfc4665eb1f5c64a | 225 | Pfam | PF00642 | Zinc finger C-x8-C-x5-C-x3-H type (and similar) | 152 | 176 | 1.7E-5 | T | 22-09-2020 | IPR000571 | Zinc finger, CCCH-type |
| UnnamedSample_HQ_transcript/102886|m.22977 | UnnamedSample_HQ_transcript/102886 | Coverage 0.604 too low. | def3ab1fb88b8ed4dfc4665eb1f5c64a | 225 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 94 | 142 | 5.5E-6 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/20907|m.7125 | UnnamedSample_HQ_transcript/20907 | Unmapped. | a0b9ce2b61299463d94dc1b40adafe2b | 681 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 5 | 265 | 1.5E-6 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/23849|m.7903 | UnnamedSample_HQ_transcript/23849 | Coverage 0.952 too low. | 87c9f993d3919dc873ec3e425be9fa11 | 919 | Pfam | PF11232 | Mediator complex subunit 25 PTOV activation and synapsin 2 | 558 | 706 | 2.5E-53 | T | 22-09-2020 | IPR021394 | Mediator complex, subunit Med25, PTOV domain |
| UnnamedSample_HQ_transcript/23849|m.7903 | UnnamedSample_HQ_transcript/23849 | Coverage 0.952 too low. | 87c9f993d3919dc873ec3e425be9fa11 | 919 | Pfam | PF11265 | Mediator complex subunit 25 von Willebrand factor type A | 11 | 217 | 3.9E-76 | T | 22-09-2020 | IPR021419 | Mediator complex, subunit Med25, von Willebrand factor type A |
| UnnamedSample_HQ_transcript/64712|m.16982 | UnnamedSample_HQ_transcript/64712 | Coverage 0.114 too low. | d3800784344677e45993804e05de9326 | 525 | Pfam | PF00397 | WW domain | 224 | 253 | 2.3E-10 | T | 22-09-2020 | IPR001202 | WW domain |
| UnnamedSample_HQ_transcript/64712|m.16982 | UnnamedSample_HQ_transcript/64712 | Coverage 0.114 too low. | d3800784344677e45993804e05de9326 | 525 | Pfam | PF08236 | SRI (Set2 Rpb1 interacting) domain | 429 | 516 | 3.2E-20 | T | 22-09-2020 | IPR013257 | Set2 Rpb1 interacting domain |
| UnnamedSample_HQ_transcript/20993|m.7144 | UnnamedSample_HQ_transcript/20993 | Coverage 0.086 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF01017 | STAT protein, all-alpha domain | 147 | 313 | 3.2E-28 | T | 22-09-2020 | IPR013800 | STAT transcription factor, all-alpha domain |
| UnnamedSample_HQ_transcript/20993|m.7144 | UnnamedSample_HQ_transcript/20993 | Coverage 0.086 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF00017 | SH2 domain | 600 | 678 | 1.6E-9 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/20993|m.7144 | UnnamedSample_HQ_transcript/20993 | Coverage 0.086 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF02865 | STAT protein, protein interaction domain | 2 | 124 | 1.1E-35 | T | 22-09-2020 | IPR013799 | STAT transcription factor, protein interaction |
| UnnamedSample_HQ_transcript/20993|m.7144 | UnnamedSample_HQ_transcript/20993 | Coverage 0.086 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF02864 | STAT protein, DNA binding domain | 348 | 480 | 2.2E-46 | T | 22-09-2020 | IPR013801 | STAT transcription factor, DNA-binding |
| UnnamedSample_HQ_transcript/14272|m.5191 | UnnamedSample_HQ_transcript/14272 | Coverage 0.057 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF01017 | STAT protein, all-alpha domain | 147 | 313 | 3.2E-28 | T | 22-09-2020 | IPR013800 | STAT transcription factor, all-alpha domain |
| UnnamedSample_HQ_transcript/14272|m.5191 | UnnamedSample_HQ_transcript/14272 | Coverage 0.057 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF00017 | SH2 domain | 600 | 678 | 1.6E-9 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/14272|m.5191 | UnnamedSample_HQ_transcript/14272 | Coverage 0.057 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF02865 | STAT protein, protein interaction domain | 2 | 124 | 1.1E-35 | T | 22-09-2020 | IPR013799 | STAT transcription factor, protein interaction |
| UnnamedSample_HQ_transcript/14272|m.5191 | UnnamedSample_HQ_transcript/14272 | Coverage 0.057 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF02864 | STAT protein, DNA binding domain | 348 | 480 | 2.2E-46 | T | 22-09-2020 | IPR013801 | STAT transcription factor, DNA-binding |
| UnnamedSample_HQ_transcript/29931|m.9466 | UnnamedSample_HQ_transcript/29931 | Coverage 0.099 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF01017 | STAT protein, all-alpha domain | 147 | 313 | 3.2E-28 | T | 22-09-2020 | IPR013800 | STAT transcription factor, all-alpha domain |
| UnnamedSample_HQ_transcript/29931|m.9466 | UnnamedSample_HQ_transcript/29931 | Coverage 0.099 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF00017 | SH2 domain | 600 | 678 | 1.6E-9 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/29931|m.9466 | UnnamedSample_HQ_transcript/29931 | Coverage 0.099 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF02865 | STAT protein, protein interaction domain | 2 | 124 | 1.1E-35 | T | 22-09-2020 | IPR013799 | STAT transcription factor, protein interaction |
| UnnamedSample_HQ_transcript/29931|m.9466 | UnnamedSample_HQ_transcript/29931 | Coverage 0.099 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF02864 | STAT protein, DNA binding domain | 348 | 480 | 2.2E-46 | T | 22-09-2020 | IPR013801 | STAT transcription factor, DNA-binding |
| UnnamedSample_HQ_transcript/25834|m.8433 | UnnamedSample_HQ_transcript/25834 | Coverage 0.105 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF01017 | STAT protein, all-alpha domain | 147 | 313 | 3.2E-28 | T | 22-09-2020 | IPR013800 | STAT transcription factor, all-alpha domain |
| UnnamedSample_HQ_transcript/25834|m.8433 | UnnamedSample_HQ_transcript/25834 | Coverage 0.105 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF00017 | SH2 domain | 600 | 678 | 1.6E-9 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/25834|m.8433 | UnnamedSample_HQ_transcript/25834 | Coverage 0.105 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF02865 | STAT protein, protein interaction domain | 2 | 124 | 1.1E-35 | T | 22-09-2020 | IPR013799 | STAT transcription factor, protein interaction |
| UnnamedSample_HQ_transcript/25834|m.8433 | UnnamedSample_HQ_transcript/25834 | Coverage 0.105 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF02864 | STAT protein, DNA binding domain | 348 | 480 | 2.2E-46 | T | 22-09-2020 | IPR013801 | STAT transcription factor, DNA-binding |
| UnnamedSample_HQ_transcript/18829|m.6536 | UnnamedSample_HQ_transcript/18829 | Coverage 0.083 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF01017 | STAT protein, all-alpha domain | 147 | 313 | 3.2E-28 | T | 22-09-2020 | IPR013800 | STAT transcription factor, all-alpha domain |
| UnnamedSample_HQ_transcript/18829|m.6536 | UnnamedSample_HQ_transcript/18829 | Coverage 0.083 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF00017 | SH2 domain | 600 | 678 | 1.6E-9 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/18829|m.6536 | UnnamedSample_HQ_transcript/18829 | Coverage 0.083 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF02865 | STAT protein, protein interaction domain | 2 | 124 | 1.1E-35 | T | 22-09-2020 | IPR013799 | STAT transcription factor, protein interaction |
| UnnamedSample_HQ_transcript/18829|m.6536 | UnnamedSample_HQ_transcript/18829 | Coverage 0.083 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF02864 | STAT protein, DNA binding domain | 348 | 480 | 2.2E-46 | T | 22-09-2020 | IPR013801 | STAT transcription factor, DNA-binding |
| UnnamedSample_HQ_transcript/16155|m.5758 | UnnamedSample_HQ_transcript/16155 | Coverage 0.981 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF01017 | STAT protein, all-alpha domain | 147 | 313 | 3.2E-28 | T | 22-09-2020 | IPR013800 | STAT transcription factor, all-alpha domain |
| UnnamedSample_HQ_transcript/16155|m.5758 | UnnamedSample_HQ_transcript/16155 | Coverage 0.981 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF00017 | SH2 domain | 600 | 678 | 1.6E-9 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/16155|m.5758 | UnnamedSample_HQ_transcript/16155 | Coverage 0.981 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF02865 | STAT protein, protein interaction domain | 2 | 124 | 1.1E-35 | T | 22-09-2020 | IPR013799 | STAT transcription factor, protein interaction |
| UnnamedSample_HQ_transcript/16155|m.5758 | UnnamedSample_HQ_transcript/16155 | Coverage 0.981 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF02864 | STAT protein, DNA binding domain | 348 | 480 | 2.2E-46 | T | 22-09-2020 | IPR013801 | STAT transcription factor, DNA-binding |
| UnnamedSample_HQ_transcript/10416|m.3962 | UnnamedSample_HQ_transcript/10416 | Coverage 0.075 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF01017 | STAT protein, all-alpha domain | 147 | 313 | 3.2E-28 | T | 22-09-2020 | IPR013800 | STAT transcription factor, all-alpha domain |
| UnnamedSample_HQ_transcript/10416|m.3962 | UnnamedSample_HQ_transcript/10416 | Coverage 0.075 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF00017 | SH2 domain | 600 | 678 | 1.6E-9 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/10416|m.3962 | UnnamedSample_HQ_transcript/10416 | Coverage 0.075 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF02865 | STAT protein, protein interaction domain | 2 | 124 | 1.1E-35 | T | 22-09-2020 | IPR013799 | STAT transcription factor, protein interaction |
| UnnamedSample_HQ_transcript/10416|m.3962 | UnnamedSample_HQ_transcript/10416 | Coverage 0.075 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF02864 | STAT protein, DNA binding domain | 348 | 480 | 2.2E-46 | T | 22-09-2020 | IPR013801 | STAT transcription factor, DNA-binding |
| UnnamedSample_HQ_transcript/14750|m.5341 | UnnamedSample_HQ_transcript/14750 | Coverage 0.052 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF01017 | STAT protein, all-alpha domain | 147 | 313 | 3.2E-28 | T | 22-09-2020 | IPR013800 | STAT transcription factor, all-alpha domain |
| UnnamedSample_HQ_transcript/14750|m.5341 | UnnamedSample_HQ_transcript/14750 | Coverage 0.052 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF00017 | SH2 domain | 600 | 678 | 1.6E-9 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/14750|m.5341 | UnnamedSample_HQ_transcript/14750 | Coverage 0.052 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF02865 | STAT protein, protein interaction domain | 2 | 124 | 1.1E-35 | T | 22-09-2020 | IPR013799 | STAT transcription factor, protein interaction |
| UnnamedSample_HQ_transcript/14750|m.5341 | UnnamedSample_HQ_transcript/14750 | Coverage 0.052 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF02864 | STAT protein, DNA binding domain | 348 | 480 | 2.2E-46 | T | 22-09-2020 | IPR013801 | STAT transcription factor, DNA-binding |
| UnnamedSample_HQ_transcript/23608|m.7836 | UnnamedSample_HQ_transcript/23608 | Coverage 0.090 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF01017 | STAT protein, all-alpha domain | 147 | 313 | 3.2E-28 | T | 22-09-2020 | IPR013800 | STAT transcription factor, all-alpha domain |
| UnnamedSample_HQ_transcript/23608|m.7836 | UnnamedSample_HQ_transcript/23608 | Coverage 0.090 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF00017 | SH2 domain | 600 | 678 | 1.6E-9 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/23608|m.7836 | UnnamedSample_HQ_transcript/23608 | Coverage 0.090 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF02865 | STAT protein, protein interaction domain | 2 | 124 | 1.1E-35 | T | 22-09-2020 | IPR013799 | STAT transcription factor, protein interaction |
| UnnamedSample_HQ_transcript/23608|m.7836 | UnnamedSample_HQ_transcript/23608 | Coverage 0.090 too low. | e96d52b168f2a8661d47daebd1ca4912 | 788 | Pfam | PF02864 | STAT protein, DNA binding domain | 348 | 480 | 2.2E-46 | T | 22-09-2020 | IPR013801 | STAT transcription factor, DNA-binding |
| UnnamedSample_HQ_transcript/49499|m.13913 | UnnamedSample_HQ_transcript/49499 | Coverage 0.971 too low. | 25c71a8530bfdc949e5958e85a94423d | 523 | Pfam | PF00013 | KH domain | 197 | 268 | 2.3E-14 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/49499|m.13913 | UnnamedSample_HQ_transcript/49499 | Coverage 0.971 too low. | 25c71a8530bfdc949e5958e85a94423d | 523 | Pfam | PF00013 | KH domain | 352 | 415 | 2.1E-14 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/49499|m.13913 | UnnamedSample_HQ_transcript/49499 | Coverage 0.971 too low. | 25c71a8530bfdc949e5958e85a94423d | 523 | Pfam | PF00013 | KH domain | 117 | 181 | 2.4E-16 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/49499|m.13913 | UnnamedSample_HQ_transcript/49499 | Coverage 0.971 too low. | 25c71a8530bfdc949e5958e85a94423d | 523 | Pfam | PF00013 | KH domain | 433 | 502 | 3.9E-17 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/49499|m.13913 | UnnamedSample_HQ_transcript/49499 | Coverage 0.971 too low. | 25c71a8530bfdc949e5958e85a94423d | 523 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 13 | 81 | 7.9E-6 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/48065|m.13596 | UnnamedSample_HQ_transcript/48065 | Coverage 0.970 too low. | 765d6357b6107f474005810669e7e811 | 637 | Pfam | PF00083 | Sugar (and other) transporter | 38 | 453 | 3.9E-36 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/57085|m.15463 | UnnamedSample_HQ_transcript/57085 | Coverage 0.892 too low. | 0003f9f3368cd623250a316a58ec263b | 471 | Pfam | PF00856 | SET domain | 10 | 56 | 4.9E-9 | T | 22-09-2020 | IPR001214 | SET domain |
| UnnamedSample_HQ_transcript/100440|m.22703 | UnnamedSample_HQ_transcript/100440 | Identity 0.937 too low. | 93af7d267e010c9949ac6e93eeeaccd9 | 250 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 1 | 144 | 2.4E-48 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/25430|m.8326 | UnnamedSample_HQ_transcript/25430 | Coverage 0.462 too low. | 3aaaee2103bb5dced98ab3f20fc02bd6 | 927 | Pfam | PF00550 | Phosphopantetheine attachment site | 195 | 255 | 2.8E-14 | T | 22-09-2020 | IPR009081 | Phosphopantetheine binding ACP domain |
| UnnamedSample_HQ_transcript/25430|m.8326 | UnnamedSample_HQ_transcript/25430 | Coverage 0.462 too low. | 3aaaee2103bb5dced98ab3f20fc02bd6 | 927 | Pfam | PF00106 | short chain dehydrogenase | 688 | 877 | 9.5E-50 | T | 22-09-2020 | IPR002347 | Short-chain dehydrogenase/reductase SDR |
| UnnamedSample_HQ_transcript/25430|m.8326 | UnnamedSample_HQ_transcript/25430 | Coverage 0.462 too low. | 3aaaee2103bb5dced98ab3f20fc02bd6 | 927 | Pfam | PF13193 | AMP-binding enzyme C-terminal domain | 90 | 165 | 3.9E-7 | T | 22-09-2020 | IPR025110 | AMP-binding enzyme, C-terminal domain |
| UnnamedSample_HQ_transcript/25430|m.8326 | UnnamedSample_HQ_transcript/25430 | Coverage 0.462 too low. | 3aaaee2103bb5dced98ab3f20fc02bd6 | 927 | Pfam | PF00501 | AMP-binding enzyme | 2 | 81 | 7.8E-16 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/25430|m.8326 | UnnamedSample_HQ_transcript/25430 | Coverage 0.462 too low. | 3aaaee2103bb5dced98ab3f20fc02bd6 | 927 | Pfam | PF07993 | Male sterility protein | 308 | 542 | 6.7E-53 | T | 22-09-2020 | IPR013120 | Male sterility, NAD-binding |
| UnnamedSample_HQ_transcript/113983|m.24298 | UnnamedSample_HQ_transcript/113983 | Coverage 0.383 too low. | 616bef529a739685a9df6a39f8f2d419 | 176 | Pfam | PF06585 | Haemolymph juvenile hormone binding protein (JHBP) | 16 | 117 | 2.0E-26 | T | 22-09-2020 | IPR010562 | Haemolymph juvenile hormone binding |
| UnnamedSample_HQ_transcript/33018|m.10214 | UnnamedSample_HQ_transcript/33018 | Identity 0.851 too low. | 9abe8d6efa0677fad5a0c1815633137f | 839 | Pfam | PF00567 | Tudor domain | 652 | 776 | 2.3E-17 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/33018|m.10214 | UnnamedSample_HQ_transcript/33018 | Identity 0.851 too low. | 9abe8d6efa0677fad5a0c1815633137f | 839 | Pfam | PF12872 | OST-HTH/LOTUS domain | 7 | 61 | 1.2E-7 | T | 22-09-2020 | IPR025605 | OST-HTH/LOTUS domain |
| UnnamedSample_HQ_transcript/16957|m.5991 | UnnamedSample_HQ_transcript/16957 | Unmapped. | 4e8a69b9f9daaf5ea0eddb6832503b17 | 1014 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 588 | 973 | 1.9E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/92882|m.21643 | UnnamedSample_HQ_transcript/92882 | Coverage 0.790 too low. | ed65e9e4abf6381e7ea0941b41e3263b | 374 | Pfam | PF05470 | Eukaryotic translation initiation factor 3 subunit 8 N-terminus | 30 | 199 | 2.2E-54 | T | 22-09-2020 | IPR008905 | Eukaryotic translation initiation factor 3 subunit C, N-terminal domain |
| UnnamedSample_HQ_transcript/99403|m.22553 | UnnamedSample_HQ_transcript/99403 | Coverage 0.827 too low. | 8c5b985f190b60ba91b73d56c75e4602 | 309 | Pfam | PF10568 | Outer mitochondrial membrane transport complex protein | 19 | 139 | 1.8E-33 | T | 22-09-2020 | IPR019564 | Mitochondrial outer membrane transport complex Sam37/metaxin, N-terminal domain |
| UnnamedSample_HQ_transcript/99403|m.22553 | UnnamedSample_HQ_transcript/99403 | Coverage 0.827 too low. | 8c5b985f190b60ba91b73d56c75e4602 | 309 | Pfam | PF17171 | Glutathione S-transferase, C-terminal domain | 166 | 229 | 5.8E-21 | T | 22-09-2020 | IPR033468 | Metaxin, glutathione S-transferase domain |
| UnnamedSample_HQ_transcript/51124|m.14269 | UnnamedSample_HQ_transcript/51124 | Coverage 0.544 too low. | f8d7d14eff558aab6188d3628cc294d1 | 412 | Pfam | PF13632 | Glycosyl transferase family group 2 | 137 | 337 | 4.0E-37 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/62269|m.16496 | UnnamedSample_HQ_transcript/62269 | Coverage 0.608 too low. | 09e8c72d9385e65f54e682afa31d3c37 | 282 | Pfam | PF00047 | Immunoglobulin domain | 2 | 52 | 1.1E-4 | T | 22-09-2020 | IPR013151 | Immunoglobulin |
| UnnamedSample_HQ_transcript/62269|m.16496 | UnnamedSample_HQ_transcript/62269 | Coverage 0.608 too low. | 09e8c72d9385e65f54e682afa31d3c37 | 282 | Pfam | PF07679 | Immunoglobulin I-set domain | 87 | 141 | 7.1E-8 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/53354|m.14711 | UnnamedSample_HQ_transcript/53354 | Coverage 0.954 too low. | bc12ef03072cb9b33ef1805fec5a7873 | 318 | Pfam | PF00067 | Cytochrome P450 | 113 | 250 | 6.5E-9 | T | 22-09-2020 | IPR001128 | Cytochrome P450 |
| UnnamedSample_HQ_transcript/53354|m.14711 | UnnamedSample_HQ_transcript/53354 | Coverage 0.954 too low. | bc12ef03072cb9b33ef1805fec5a7873 | 318 | Pfam | PF00067 | Cytochrome P450 | 49 | 106 | 1.1E-5 | T | 22-09-2020 | IPR001128 | Cytochrome P450 |
| UnnamedSample_HQ_transcript/11497|m.4324 | UnnamedSample_HQ_transcript/11497 | Coverage 0.940 too low. | 2398f809751af9d7d5448732e382df70 | 1261 | Pfam | PF00754 | F5/8 type C domain | 34 | 159 | 5.9E-22 | T | 22-09-2020 | IPR000421 | Coagulation factor 5/8 C-terminal domain |
| UnnamedSample_HQ_transcript/11497|m.4324 | UnnamedSample_HQ_transcript/11497 | Coverage 0.940 too low. | 2398f809751af9d7d5448732e382df70 | 1261 | Pfam | PF00008 | EGF-like domain | 953 | 976 | 1.3E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/11497|m.4324 | UnnamedSample_HQ_transcript/11497 | Coverage 0.940 too low. | 2398f809751af9d7d5448732e382df70 | 1261 | Pfam | PF00008 | EGF-like domain | 531 | 560 | 8.3E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/11497|m.4324 | UnnamedSample_HQ_transcript/11497 | Coverage 0.940 too low. | 2398f809751af9d7d5448732e382df70 | 1261 | Pfam | PF02210 | Laminin G domain | 383 | 501 | 3.3E-16 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/11497|m.4324 | UnnamedSample_HQ_transcript/11497 | Coverage 0.940 too low. | 2398f809751af9d7d5448732e382df70 | 1261 | Pfam | PF02210 | Laminin G domain | 1019 | 1142 | 2.9E-14 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/11497|m.4324 | UnnamedSample_HQ_transcript/11497 | Coverage 0.940 too low. | 2398f809751af9d7d5448732e382df70 | 1261 | Pfam | PF02210 | Laminin G domain | 809 | 930 | 1.2E-18 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/11497|m.4324 | UnnamedSample_HQ_transcript/11497 | Coverage 0.940 too low. | 2398f809751af9d7d5448732e382df70 | 1261 | Pfam | PF02210 | Laminin G domain | 198 | 318 | 1.8E-24 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/101745|m.22838 | UnnamedSample_HQ_transcript/101745 | Coverage 0.666 too low. | 895581223efbf95338beea3a6818574b | 204 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 119 | 202 | 1.5E-12 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/101745|m.22838 | UnnamedSample_HQ_transcript/101745 | Coverage 0.666 too low. | 895581223efbf95338beea3a6818574b | 204 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 21 | 111 | 1.8E-12 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/28934|m.9208 | UnnamedSample_HQ_transcript/28934 | Identity 0.834 too low. | 0162d3ff790e3cf3fbabbb089448a618 | 333 | Pfam | PF00970 | Oxidoreductase FAD-binding domain | 110 | 188 | 1.4E-10 | T | 22-09-2020 | IPR008333 | Flavoprotein pyridine nucleotide cytochrome reductase-like, FAD-binding domain |
| UnnamedSample_HQ_transcript/28934|m.9208 | UnnamedSample_HQ_transcript/28934 | Identity 0.834 too low. | 0162d3ff790e3cf3fbabbb089448a618 | 333 | Pfam | PF09791 | Oxidoreductase-like protein, N-terminal | 4 | 37 | 5.5E-10 | T | 22-09-2020 | IPR019180 | Oxidoreductase-like, N-terminal |
| UnnamedSample_HQ_transcript/28934|m.9208 | UnnamedSample_HQ_transcript/28934 | Identity 0.834 too low. | 0162d3ff790e3cf3fbabbb089448a618 | 333 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 204 | 316 | 1.7E-12 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
| UnnamedSample_HQ_transcript/63336|m.16698 | UnnamedSample_HQ_transcript/63336 | Identity 0.944 too low. | 0162d3ff790e3cf3fbabbb089448a618 | 333 | Pfam | PF00970 | Oxidoreductase FAD-binding domain | 110 | 188 | 1.4E-10 | T | 22-09-2020 | IPR008333 | Flavoprotein pyridine nucleotide cytochrome reductase-like, FAD-binding domain |
| UnnamedSample_HQ_transcript/63336|m.16698 | UnnamedSample_HQ_transcript/63336 | Identity 0.944 too low. | 0162d3ff790e3cf3fbabbb089448a618 | 333 | Pfam | PF09791 | Oxidoreductase-like protein, N-terminal | 4 | 37 | 5.5E-10 | T | 22-09-2020 | IPR019180 | Oxidoreductase-like, N-terminal |
| UnnamedSample_HQ_transcript/63336|m.16698 | UnnamedSample_HQ_transcript/63336 | Identity 0.944 too low. | 0162d3ff790e3cf3fbabbb089448a618 | 333 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 204 | 316 | 1.7E-12 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
| UnnamedSample_HQ_transcript/1078|m.670 | UnnamedSample_HQ_transcript/1078 | Coverage 0.858 too low. | e326b9aa0bab16f5081c83b4b93be1c1 | 1119 | Pfam | PF00052 | Laminin B (Domain IV) | 581 | 716 | 4.9E-23 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/1078|m.670 | UnnamedSample_HQ_transcript/1078 | Coverage 0.858 too low. | e326b9aa0bab16f5081c83b4b93be1c1 | 1119 | Pfam | PF00053 | Laminin EGF domain | 751 | 798 | 3.7E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1078|m.670 | UnnamedSample_HQ_transcript/1078 | Coverage 0.858 too low. | e326b9aa0bab16f5081c83b4b93be1c1 | 1119 | Pfam | PF00053 | Laminin EGF domain | 417 | 461 | 1.2E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1078|m.670 | UnnamedSample_HQ_transcript/1078 | Coverage 0.858 too low. | e326b9aa0bab16f5081c83b4b93be1c1 | 1119 | Pfam | PF00053 | Laminin EGF domain | 859 | 909 | 2.2E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1078|m.670 | UnnamedSample_HQ_transcript/1078 | Coverage 0.858 too low. | e326b9aa0bab16f5081c83b4b93be1c1 | 1119 | Pfam | PF00053 | Laminin EGF domain | 959 | 1003 | 2.3E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1078|m.670 | UnnamedSample_HQ_transcript/1078 | Coverage 0.858 too low. | e326b9aa0bab16f5081c83b4b93be1c1 | 1119 | Pfam | PF00053 | Laminin EGF domain | 1006 | 1045 | 3.7E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1078|m.670 | UnnamedSample_HQ_transcript/1078 | Coverage 0.858 too low. | e326b9aa0bab16f5081c83b4b93be1c1 | 1119 | Pfam | PF00053 | Laminin EGF domain | 717 | 741 | 1.2E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1078|m.670 | UnnamedSample_HQ_transcript/1078 | Coverage 0.858 too low. | e326b9aa0bab16f5081c83b4b93be1c1 | 1119 | Pfam | PF00053 | Laminin EGF domain | 801 | 856 | 1.1E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1078|m.670 | UnnamedSample_HQ_transcript/1078 | Coverage 0.858 too low. | e326b9aa0bab16f5081c83b4b93be1c1 | 1119 | Pfam | PF00053 | Laminin EGF domain | 326 | 374 | 3.1E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1078|m.670 | UnnamedSample_HQ_transcript/1078 | Coverage 0.858 too low. | e326b9aa0bab16f5081c83b4b93be1c1 | 1119 | Pfam | PF00053 | Laminin EGF domain | 912 | 956 | 1.9E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
